Imexhs Limited (A$1.65) SPEC BUY TP A$2.73 Democratising imaging technology IME is a next generation cloud-based medical imaging solution for healthcare organisations. Its affordable and multimodal enterprise solution enables for a whole-of-hospital approach and accessible by markets which are underserved by the large global providers. Recent regulatory approvals in US and Brazil has opened up further opportunities with a recent capital injection now allowing an acceleration into larger global markets. IME trades at a significant discount to peers which we believe will reduce as further contracts ex-LATAM are won and the company approaches profitability. Company guidance suggests a continuation of contracted revenue growth and profitability on the near-term horizon. We continue to remain overweight in the medical imaging thematic with strong tailwinds and shift to technologies which allow a whole of hospital approach. We initiate coverage on IME with a Speculative Buy recommendation and price target of A$2.73.Click here for more...
IME Price at posting:
$1.63 Sentiment: Buy Disclosure: Held
